Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (6): 837-841    DOI: 10.12891/ceog4212.2018
Original Research Previous articles | Next articles
Maternal and perinatal outcomes in early onset and late onset preeclampsia
A. Simsek1, *(), S. Uludag1, A. Tuten1, A. S. Acikgoz1, S. Uludag1
1 Istanbul University, Cerrahpasa School of Medicine, Department of Obstetric and Gynecology, Istanbul, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: This study was performed to compare the clinical findings and identify differences in risk factors between early-onset preeclampsia (EO-PE) and late-onset preeclampsia (LO-PE). Materials and Methods: This retrospective study included 516 women with singleton pregnancies and preeclampsia (none of them had superimposed preeclampsia on chronic hypertension) who delivered in a tertiary care center. Clinical findings, and maternal and perinatal outcomes were compared between early (< 34 weeks’ gestation) and late (≥ 34 weeks’ gestation) onset of the disease. Results: Incidences of nulliparity, previous preterm births, stillbirths, and first trimester abortions were significantly higher in women with EO-PE (p < 0.05). History of disease other than chronic hypertension (especially diabetes mellitus) and previous term births were significantly higher in women with late-onset disease (p < 0.05). The mean gestational week at delivery and mean birth weight were significantly lower in early-onset disease (p < 0.05). Stillbirths, early and late neonatal deaths, and cases where the mother’s life at risk were significantly higher in women with early-onset disease (p < 0.05). Conclusions: EO-PE appears to be mediated by the placenta and associated with higher incidence of perinatal, neonatal and maternal deaths, and maternal nearmiss cases.
Key words:  Preeclampsia      EO-PE, LO-PE      Maternal mortality      Perinatal mortality     
Published:  10 December 2018     
*Corresponding Author(s):  A. SIMSEK     E-mail:  draksimsek@yahoo.com.tr

Cite this article: 

A. Simsek, S. Uludag, A. Tuten, A. S. Acikgoz, S. Uludag. Maternal and perinatal outcomes in early onset and late onset preeclampsia. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 837-841.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4212.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I6/837

[1] H.M. Kim, Y.S. Choo, W.J. Seong. Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 511-515.
[2] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[3] A.E. Kholeif, M.Y. Khamis, S. Eltabakh, R.S. Swilam, A. Elhabashy, R. EISherif. Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 183-188.
[4] J. Yoon Park, S.W. Lee, K.J. Oh, J.-S. Hong. High mean blood pressure during the first trimester is predictive of future preeclampsia development in healthy pregnant women: a cohort study in Korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 770-775.
[5] Y.E. Purut, E.E. Buyukbayrak, F. Ercan, A. Orcun, M. Menke, A.Y. Karageyim Karsidag. Do first trimester maternal serum follistatin like 3 levels predict preeclampsia and/or related adverse pregnancy outcomes?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 195-200.
[6] E. Ertekin, Ö. Tunçyürek, S. Kafkas, Y. Özsunar. Does the placental strain ratio correlate with the umbilical artery Doppler values?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 227-230.
[7] B. Dullaert, S. Schroven, Y. Jacquemyn. The effect of maternal vitamin D status on pregnancy outcome and child health in the first year of life[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 677-681.
[8] Jinqi Ma, Hua Yao. Persistent hypertension post-preeclampsia: a tertiary care centre-based study in China[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 741-744.
[9] R. Einikytė, A. Dapkeviciute, V. Dzenkeviciute, S. Kasnauskiene, V. Sapoka, D. Ramasauskaite. The importance of angiogenic and antiangiogenic biomarkers in pathogenesis and early diagnosis of preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 485-492.
[10] H. Kobayashi, T. Tsunemi, J. Akasaka, N. Koike, A. Shigemitsu. F. Ito, Y. Yamada, E. Fujii. Preeclampsia as a parental epigenetic disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 493-502.
[11] A. Jafari, S. Parchami, S. Reiisi, S. Miraj. Association of plasma homocysteine, folic acid levels, and C677T polymorphism in methylene tetra hydrofolate reductase with risk of preeclampsia: a case-control study in Iranian women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 367-374.
[12] W.Y. Gong, Y.P. Li, C.T. Zuo, X.T. Wang. Clinical characteristics and pregnancy outcomes in parturients with pulmonary hypertension: experience with 39 consecutive cases from China[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 257-261.
[13] E. Shim, J.Y. Park, H.J. Seol. Placental expression of retinol-binding protein 4 in patients with preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 98-101.
[14] R. Lukic, M. Djukic, I. Soldatovic, N. Karadzov Orlic, D. Ardalic, G. Dragovic, Z. Mikovic. Prediction of preeclampsia using extreme first-trimester PAPP-A, free βhCG and uterine artery Doppler in resource limited settings[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 851-855.
[15] T. Tsunemi, T. Sado, K. Naruse, H. Kobayashi. Paternal contribution to the preeclampsia phenotype[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 914-922.
No Suggested Reading articles found!